Print ISSN: 2790-0207

Online ISSN: 2790-0215

Keywords : Iraq


Anemia in Pregnant Women in Kirkuk Governorate

Mohammed Ali Khalaf; Dalia Maher Khider; Bilal Jamal Kamal

Kirkuk Journal of Medical Sciences, 2020, Volume 8, Issue 1, Pages 78-85

Background: Anemia is defined as hemoglobin levels of ≤ 11 g/dl , is one of the world's leading causes of disability , and thus one of the most serious global public health problems .More than (50%) of the pregnant women in the world are anemic. Knowledge about the anemia is very important in our community. This knowledge will encourage those who work in primary health care (PHCS) provider for pregnant women to detect the problem earlier and treat the problem properly.
Aims: Is to determine the effective factors related to anemia in pregnant women in Kirkuk governorate. Patient & Method: A total of 250 pregnant women were asked while attending antenatal unit in Azadi Teaching Hospital and several Primary Health Centers in Kirkuk City out patients clinic from 25.10. 2014 to1.3.2015. Data were taken involve: age, residency, educational level, history of last menstrual period, onset of anemia and level of hemoglobin (Hb). These data were organized in special questionnaire prepared for this purpose.
Results: From the total (250) pregnant women (61.6%) of them have low Hemoglobin (Hb) level mild, moderate or severe anemia the majority of them (75.33%) with mild anemia. according to severity the rate was (3.2%).
Conclusions and Recommendations: The prevalence of anemia among women in Kirkuk city during pregnancy is high (61.6%) in compare to (52%) in the world wide in developing countries.

Assessment of Patient‘s Experience with the Referral between Primary and Secondary Health Care in Mosul

Mayson Ghanim Mohammad Al-Ubaidy; Elham Khattab Aljammas

Kirkuk Journal of Medical Sciences, 2018, Volume 6, Issue 1, Pages 157-165

Background: Referral is a dynamic process and it had been recognized as crucial since the Alma Ata declaration in 1978. Hospitals are overcrowded with patients who could be more cheaply treated in smaller facilities is a common feature of poorly functioning Referral System. Objective: This study aimed to assess patients‘ experience with quality of patient referral between levels of health care. Methods: A cross-sectional study was conducted in Mosul. A questionnaire was administered to 406 patients formally referred to al-Mosul General Hospital. Data was collected on socio-demographic characteristics of referred patients, appropriateness of referral process, and patient satisfaction. Result: The mean age of the group was 28.25 + 18.29 years and female's form (55.4%) of clients, (49%) believes that the referral process was appropriate. Two third of patients believe that three to four areas of the referring process was appropriate, while (65.5%) of clients were satisfied, with the treatment provided, that only statistically significant for type of referring center. Conclusion: Patients in this study view the referrals to higher levels of care as appropriate, with a high rate of referral to obtain diagnosis, to get specific treatment, and self-requested referrals that not be explained by socio-demographic characteristics of the patients, and most of them were satisfied by services provided through referral.

Transfusion-Related Infections in Thalassemia Major Patients: Kirkuk Thalassemia Center Experience

Jamal Qassim Welli; Majed Najii Agha; Mohammed Saleem Mohammed

Kirkuk Journal of Medical Sciences, 2015, Volume 3, Issue 1, Pages 22-28

Introduction: Thalassemia Major is one of the commonest causes of hereditary anemia in Iraq. Patients usually require frequent blood transfusion. This study tried to estimate the problem of transfusion-related infections among β-thalassemia major patients in Kirkuk governorate-Iraq.
Patients and Methods: The study involved 254 multi-transfused thalassemia major patients attending the Thalassemia Center at Kirkuk governorate over twoyears periodstarting from January 2010 to January 2012. Blood samples were tested for HBsAg, anti HCV antibodies, and HIV antibody using an enzyme-linked immunosorbent assay. A control group of 150 Thalassemia minor with nearly matched age and sex to thalassemia major patients was included.
Results: Anti-HCV antibody was positive in 85 out of 254 thalassemia major patients (33.5%), while HBsAg was positive in only one out of 254 patients (0.4%). HIV infection was not found in any thalassemia major patients. The rate of positive anti-HCV antibodies was significantly higher in comparison with the control group (P value <0.000) while it was not significant for HBsAg (P value=0.9). Age categorization for thalassemia major patients with positive HCV test shows that more than three quarters of them are above 10 years old.
Conclusion:HCV is the current major problem in multi-transfused children with thalassemia major and more careful pre-transfusion screening of blood for anti-HCV must be introduced in blood bank centers.

Deferoxamine vs. Deferasirox in the Treatment of Thalassemia Major with Iron Overload: Retrospective Study in Thalassemia Center, Kirkuk, Iraq

Jamal Qasim Weli; Mohammed Saleem Mohammed

Kirkuk Journal of Medical Sciences, 2013, Volume 1, Issue 2, Pages 30-36

Background: Iron overload is a major problem in patients with Thalassemia major. An effective and safe iron chelator protocol with high compliance rate plays an important role deciding the best treatment option in these patients. This study was done to assess the efficacy and safety of both Deferoxamine and Deferasirox in Thalassemia major patients in Kirkuk province, Iraq. Patients and methods: In this retrospective study we have included serum ferritin records of 280 Thalassemia major patients treated with two types of iron chelating therapy at Thalassemia center, Azadi teaching Hospital, Kirkuk province, Iraq. The study started since March 2012 till December 2012 and they were categorized in to two groups; First group Thalassemia major patients who had been treated with subcutaneous (SC infusion) Deferoxamine, while second group had been treated with oral Deferasirox (Exjade) with serum ferritin records of both base line and 9 month later had been compared. Most patients with relatively high serum ferritin had been treated with SC Deferoxamine. As a secondary end point, side effect profile had been analyzed in the two studied groups. Results: 173 Thalassemia major patients (mean age 11 year) treated with oral Deferasirox (Exjade) had mean decrease in their serum ferritin after 9 month was 840 ng/ml while the mean decrease in the 107 patients (mean age=17 year) treated with SC infusion Deferoxamine was (1527 ng/ml) with very significant difference between the two studied groups and (p-value = 0.0005). Abdominal cramp, nausea and vomiting, skin rash were more with oral Desferosix (Exjade) than SC Deferoxamine treated patients [52 (30%), 62 (35%), 13 (7%) versus 23 (21%), 11 (10%), 0 (0%) consecutively]. Renal impairment especially elevation of serum Creatinine to a degree requiring dose modification were found in 15 patients treated with oral Deferasirox (Exjade) while it has not been noticed in patients treated with Deferoxamine. Conclusion: In spite of less side effects and more compliance of Thalassemia Major Patients treated with Deferasirox than Deferoxamine; Deferoxamine still is more effective treatment modality than Deferasirox in decreasing serum ferritin level.